Search results for: James Brian Byrd

Items from 1 to 6 out of 6 results

article

Personalized Medicine and the Treatment of Hypertension

Sarah Melville, James Brian Byrd

Current Hypertension Reports > 2019 > 21 > 2 > 1-6

Purpose of Review The purpose of this review is to discuss the implications of personalized medicine for the treatment of hypertension, including resistant hypertension. Recent Findings We suggest a framework for the personalized treatment of hypertension based on the concept of a trade-off between simplicity and personalization. This framework is based on treatment strategies classified as low,...

article

PROGNOSTIC IMPORTANCE OF BLOOD PRESSURE AND HEART RATE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: THE SUMMIT TRIAL

James Brian Byrd, David E. Newby, Julie A. Anderson, Peter M.A. Calverley, more

Journal of the American College of Cardiology > 2017 > 69 > 11(S) > 1764

article

The Contribution of the ACCOMPLISH Trial to the Treatment of Stage 2 Hypertension

James Brian Byrd, George Bakris, Kenneth Jamerson

Current Hypertension Reports > 2014 > 16 > 3 > 1-5

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) recommended a thiazide-like diuretic, alone or in combination with other antihypertensive drug classes, as initial therapy for hypertension. JNC 7, however, did not specify preferred combinations. The Avoiding Cardiovascular Events through Combination Therapy in Patients...

article

Anxiety in the “Age of Hypertension”

James Brian Byrd, Robert D. Brook

Current Hypertension Reports > 2014 > 16 > 10 > 1-7

In the USA, hypertension affects one in three adults, and anxiety disorders are the most commonly diagnosed mental health disorders. Both hypertension and anxiety have been studied extensively. Yet, a full understanding of anxiety’s relationship to hypertension has been elusive. In this review, we discuss the spectrum of anxiety disorders. In addition, we consider the evidence for acute and long-term...

article

Data quality of an electronic health record tool to support VA cardiac catheterization laboratory quality improvement: The VA Clinical Assessment, Reporting, and Tracking System for Cath Labs (CART) program

James Brian Byrd, Rebecca Vigen, Mary E. Plomondon, John S. Rumsfeld, more

American Heart Journal > 2013 > 165 > 3 > 434-440

Electronic health records (EHRs) have been identified as a key tool for quality improvement (QI) in health care. However, EHR data must be of sufficient quality to support QI efforts. In 2005, the Department of Veterans Affairs (VA) began using a novel EHR tool—the CART Program—to support QI in cardiac catheterization laboratories. We evaluated whether data collected by the CART Program were of sufficient...

article

Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor–induced peritracheal edema

James Brian Byrd, Ajai Shreevatsa, Pradeep Putlur, Denis Foretia, more

The Journal of Allergy and Clinical Immunology > 2007 > 120 > 2 > 403-408

Serum dipeptidyl peptidase IV (DPPIV) activity is decreased in some individuals with ACE inhibitor–associated angioedema. ACE and DPPIV degrade substance P, an edema-forming peptide. The contribution of impaired degradation of substance P by DPPIV to the pathogenesis of ACE inhibitor–associated angioedema is unknown.We sought to determine whether DPPIV deficiency results in increased edema formation...

Filter options

Publication date

Set your own date range

Keywords

ANGIOTENSIN-CONVERTING ENZYME INHIBITOR (2)
BLOOD PRESSURE (2)
HYPERTENSION (2)
ADHERENCE (1)
ANGIOEDEMA (1)
ANXIETY (1)
CALCIUM CHANNEL ANTAGONIST (1)
CLINICAL TRIALS (1)
COMBINATION ANTIHYPERTENSIVE DRUG THERAPY (1)
DIPEPTIDYL PEPTIDASE IV (1)
HYPERVENTILATION (1)
LARYNX (1)
MAGNETIC RESONANCE IMAGING (1)
NEUROKININ (1)
PERSONALIZED MEDICINE (1)
PHARMACOGENETICS (1)
POPULATION HEALTH (1)
PRIMARY ALDOSTERONISM (1)
PSEUDOPHEOCHROMOCYTOMA (1)
RESISTANT HYPERTENSION (1)
SPANTIDE (1)
SUBSTANCE P (1)
THIAZIDE DIURETICS (1)
TRACHEA (1)
more

Data set

Elsevier (3)
Springer (3)

INFONA - science communication portal

Search results for: James Brian Byrd

Personalized Medicine and the Treatment of Hypertension

PROGNOSTIC IMPORTANCE OF BLOOD PRESSURE AND HEART RATE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: THE SUMMIT TRIAL

The Contribution of the ACCOMPLISH Trial to the Treatment of Stage 2 Hypertension

Anxiety in the “Age of Hypertension”

Data quality of an electronic health record tool to support VA cardiac catheterization laboratory quality improvement: The VA Clinical Assessment, Reporting, and Tracking System for Cath Labs (CART) program

Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor–induced peritracheal edema

Add recipient

Sending message cancelled

Are you sure you want to cancel sending this message?

Send message

Filter options

Publication date

Date range setting

Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.

Keywords

Data set

Journal

Reporting an error / abuse

Sending the report failed

Accessibility options